Oseltamivir 30mg Oral Suspension from Canada
Oseltamivir 30mg oral suspension is a liquid formulation for pediatric influenza treatment, containing oseltamivir phosphate in measured doses. It qualifies for HTS 3004.90.92.04 as a mixed antiviral product put up for retail sale specifically containing oseltamivir salts.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals Annex IV: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Provide stability data and child-resistant packaging certification for liquid formulations
• Ensure NDC numbering and prescription labeling compliant with US pharmacopeia standards
• Declare exact oseltamivir concentration to avoid reclassification as a general mixture